Response to letter by Azziz R., et al. by Casarini, Livio & Brigante, Giulia
23/10/2020 Response to letter by Azziz R., et al | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic
https://academic.oup.com/jcem/article/100/2/L24/2835557 1/5
Response to letter by Azziz R., et al 
 
The Journal of Clinical Endocrinology &
Metabolism, Volume 100, Issue 2, 1
February 2015, Page L24,
https://doi.org/10.1210/jc.2014-4488
Published:  01 February 2015
Article history 
Livio Casarini, Giulia Brigante
Issue Section:  Correspondence
We appreciate the opportunity to
respond to the comments and matters
raised by Azziz et al regarding our
article, “The polycystic ovary syndrome
evolutionary paradox: a genome-wide
association studies-based, in silico,
evolutionary explanation” (1). We thank
these authors for their comments and
for bringing up a stimulating discussion,
which re ects the di culties in de ning
clear di erent polycystic ovary
syndrome (PCOS) phenotypes. With this
OPEN

23/10/2020 Response to letter by Azziz R., et al | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic
https://academic.oup.com/jcem/article/100/2/L24/2835557 2/5
letter, we have the possibility to better
explain our opinion in this regard.
We agree with Azziz et al about the
intimate connection of PCOS clinical
features, from the androgenic to the
metabolic ones. Our intention was to
de ne a prevalent trait for each group,
having in mind that the phenotypes of
PCOS are hardly separable. This has been
summarized at the end of the
introductive paragraph of PCOS
phenotypic features. The use of the
nomenclature, metabolic phenotype and
hyperandrogenic phenotype, was aimed
at simplifying the comparison of
di erent genetic clusters for an easier
presentation of the results.
It is true that any classi cation of the
PCOS phenotypes is itself limited by the
wide range of clinical symptoms of this
syndrome (2) and the lack of
mathematical models for de ning them.
Even if supported by many authors (2),
the suggested di erentiation in
hyperandrogenic and
nonhyperandrogenic forms is, in our
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opinion, not fully representative of the
global possible phenotypes. As
previously suggested (3, 4) and recently
remarked by The European Society of
Endocrinology (5), our data support an
important role of the metabolic changes
in PCOS-a ected women. We think that
the metabolic issue must be added to the
nomenclature suggested by Azziz et al
(2) in order to better de ne such a
complex syndrome.
In general, all the classi cations of
human diseases must be carefully taken
into account because of the intrinsic
nonmathematical nature of the medical
science.
Regarding the comment about the
previous studies about PCOS and the
possible referral and observer bias, we
agree that some limits could exist. But
we also have to trust the peer-reviewed
literature, published in prestigious
international journals. The suggestion of
developing a statistical system to
compensate for this bias is of great
interest, and it encourages future studies
OPEN

23/10/2020 Response to letter by Azziz R., et al | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic
https://academic.oup.com/jcem/article/100/2/L24/2835557 4/5




PCOS polycystic ovary syndrome.
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